On World Cancer Day, Eindhoven-based Sirius Medical, a medical device company, announced that it has secured €10M in additional scale-up funding.
This investment round was led by Invest-NL and Nextgen Ventures, with support from the De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and Sirius Medical’s team.
Founded in 2020, Invest-NL is an impact investment firm focused on driving sustainability and innovation in the Netherlands.
The firm finances visionary entrepreneurs and projects that contribute to the future economy, aiming for both impact and financial returns.
“At Invest-NL our healthcare focus is on investing in innovations that aim to avoid, replace, or relocate expensive care,” says Karin Steffens, senior investment manager at Invest-NL commented.
“Sirius Medical’s mission to develop sustainable technology solutions while maintaining balance within the healthcare system closely aligns with our mission to accelerate the healthcare transition. We are excited to back a company making such a meaningful difference for women with breast cancer,” adds Steffens.
The announcement comes around two years after raising €12M in a Series B round of funding led by Holland Capital.
Fund utilisation
The Dutch company will use the funds to enhance the Sirius Pintuition system and GPSDetect software platform, focusing on usability and intuitiveness, and extending its applications.
Additionally, the investment will accelerate the sales infrastructure and support expansion into new markets.
“Announcing this funding milestone on World Cancer Day underscores the urgency of our mission to improve cancer care globally,” says Bram Schermers, CEO of Sirius Medical.
“This funding round, in the current fundraising environment, is a clear testament to the talent of the Sirius Medical team, and the Pintuition technology that we have developed. We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical. We will have more exciting news to announce soon, adds Schermers.
World Cancer Day, observed on February 4th, is a global initiative to raise awareness, inspire action, and work together to reduce the impact of cancer worldwide.
Sirius Medical: Improving care for cancer patients
Led by CEO Bram Schermers, Sirius Medical aims to improve care for cancer patients by delivering solutions that enable precise and efficient removal of tumours.
The company’s Pintuition technology provides surgeons with real-time distance and directional navigational guidance to locate tumours accurately.
Praised by breast cancer surgeons worldwide, the Sirius Pintuition surgical navigation platform enables simple, best-in-class wire-free localisation for breast-conserving surgery in any hospital.
Sirius Medical is rapidly expanding with over 250 centres and 35.000 procedures globally,
With over 250 active centres and over 35,000 successful Pintuition procedures across Western Europe and the US. The Pintuition technology is both CE-marked and FDA-cleared.
“The Sirius Medical leadership team has shown exceptional expertise and adaptability,” says Roel Dekkers, Investment Manager, NextGen Ventures. “The company is well positioned for expansion, and we see a tremendous opportunity for growth in untapped markets.”
01
From employee advocacy to social selling: Oktopost founder Daniel Kushner on the future of B2B marketing